{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Ryanodine : Questions médicales les plus fréquentes",
"headline": "Ryanodine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Ryanodine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-07",
"dateModified": "2025-04-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Ryanodine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pyrroles",
"url": "https://questionsmedicales.fr/mesh/D011758",
"about": {
"@type": "MedicalCondition",
"name": "Pyrroles",
"code": {
"@type": "MedicalCode",
"code": "D011758",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.129.578"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Ryanodine",
"alternateName": "Ryanodine",
"code": {
"@type": "MedicalCode",
"code": "D012433",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Takashi Murayama",
"url": "https://questionsmedicales.fr/author/Takashi%20Murayama",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan."
}
},
{
"@type": "Person",
"name": "Nagomi Kurebayashi",
"url": "https://questionsmedicales.fr/author/Nagomi%20Kurebayashi",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan."
}
},
{
"@type": "Person",
"name": "Zhiguang Yuchi",
"url": "https://questionsmedicales.fr/author/Zhiguang%20Yuchi",
"affiliation": {
"@type": "Organization",
"name": "Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, Collaborative Innovation Center of Chemical Science and Engineering, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072,China."
}
},
{
"@type": "Person",
"name": "Andrew R Marks",
"url": "https://questionsmedicales.fr/author/Andrew%20R%20Marks",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Hadiatullah Hadiatullah",
"url": "https://questionsmedicales.fr/author/Hadiatullah%20Hadiatullah",
"affiliation": {
"@type": "Organization",
"name": "Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, Collaborative Innovation Center of Chemical Science and Engineering, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072,China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Strategies for Therapeutic Amelioration of Aberrant Plasma Zn",
"datePublished": "2022-09-07",
"url": "https://questionsmedicales.fr/article/36142215",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms231810302"
}
},
{
"@type": "ScholarlyArticle",
"name": "How to convert whole-blood donors to plasma donors: An investigation of the mechanisms of awareness of need for plasma and donors' perception of response efficacy.",
"datePublished": "2023-04-01",
"url": "https://questionsmedicales.fr/article/37002707",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/trf.17316"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of cardiopulmonary bypass on plasma and erythrocytes oxylipins.",
"datePublished": "2023-08-29",
"url": "https://questionsmedicales.fr/article/37644527",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12944-023-01906-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Plasma transfusion practices: A multicentre electronic audit.",
"datePublished": "2022-09-14",
"url": "https://questionsmedicales.fr/article/36102150",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/vox.13355"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Successful Recovery of a Critically Ill COVID-19 Patient, Following the Combination of Therapeutic Plasma Exchange and Convalescent Plasma Transfusion: A Case Report.",
"datePublished": "2022-08-12",
"url": "https://questionsmedicales.fr/article/36013555",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/medicina58081088"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétéromonocycliques",
"item": "https://questionsmedicales.fr/mesh/D006573"
},
{
"@type": "ListItem",
"position": 4,
"name": "Azoles",
"item": "https://questionsmedicales.fr/mesh/D001393"
},
{
"@type": "ListItem",
"position": 5,
"name": "Pyrroles",
"item": "https://questionsmedicales.fr/mesh/D011758"
},
{
"@type": "ListItem",
"position": 6,
"name": "Ryanodine",
"item": "https://questionsmedicales.fr/mesh/D012433"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Ryanodine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Ryanodine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Ryanodine",
"description": "Comment le ryanodine est-il utilisé dans le diagnostic médical ?\nQuels tests peuvent impliquer le ryanodine ?\nLe ryanodine aide-t-il à diagnostiquer des maladies spécifiques ?\nQuels marqueurs sont affectés par le ryanodine ?\nLe ryanodine est-il utilisé dans des études cliniques ?",
"url": "https://questionsmedicales.fr/mesh/D012433?mesh_terms=Plasma&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Ryanodine",
"description": "Quels symptômes sont associés à une dysfonction du ryanodine ?\nLe ryanodine peut-il provoquer des effets secondaires ?\nComment le ryanodine affecte-t-il le cœur ?\nY a-t-il des symptômes neurologiques liés au ryanodine ?\nLe ryanodine influence-t-il la respiration ?",
"url": "https://questionsmedicales.fr/mesh/D012433?mesh_terms=Plasma&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Ryanodine",
"description": "Comment prévenir les effets indésirables du ryanodine ?\nY a-t-il des recommandations alimentaires pour les utilisateurs de ryanodine ?\nLes patients doivent-ils éviter certains médicaments avec le ryanodine ?\nComment évaluer le risque d'effets secondaires ?\nLe suivi médical est-il important lors de l'utilisation du ryanodine ?",
"url": "https://questionsmedicales.fr/mesh/D012433?mesh_terms=Plasma&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Ryanodine",
"description": "Comment le ryanodine est-il utilisé en traitement ?\nLe ryanodine est-il administré par voie orale ?\nQuels médicaments interagissent avec le ryanodine ?\nLe ryanodine est-il utilisé en anesthésie ?\nY a-t-il des alternatives au ryanodine ?",
"url": "https://questionsmedicales.fr/mesh/D012433?mesh_terms=Plasma&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Ryanodine",
"description": "Quelles complications peuvent survenir avec le ryanodine ?\nLe ryanodine peut-il causer des dommages permanents ?\nComment gérer les complications liées au ryanodine ?\nLes complications sont-elles prévisibles ?\nLe ryanodine peut-il interagir avec d'autres traitements ?",
"url": "https://questionsmedicales.fr/mesh/D012433?mesh_terms=Plasma&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Ryanodine",
"description": "Quels sont les facteurs de risque liés au ryanodine ?\nL'âge influence-t-il les risques associés au ryanodine ?\nY a-t-il des prédispositions génétiques au ryanodine ?\nLes habitudes de vie affectent-elles les risques ?\nLes interactions médicamenteuses sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D012433?mesh_terms=Plasma&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment le ryanodine est-il utilisé dans le diagnostic médical ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est utilisé pour évaluer les dysfonctionnements du calcium dans les muscles."
}
},
{
"@type": "Question",
"name": "Quels tests peuvent impliquer le ryanodine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de contraction musculaire et des études de flux calcique peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Le ryanodine aide-t-il à diagnostiquer des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut aider à diagnostiquer des myopathies liées à des anomalies du calcium."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont affectés par le ryanodine ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut influencer les niveaux de calcium intracellulaire et les enzymes musculaires."
}
},
{
"@type": "Question",
"name": "Le ryanodine est-il utilisé dans des études cliniques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est utilisé dans des études sur les troubles musculaires et cardiaques."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à une dysfonction du ryanodine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des crampes musculaires, une faiblesse et des douleurs peuvent survenir."
}
},
{
"@type": "Question",
"name": "Le ryanodine peut-il provoquer des effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets comme des troubles de la contraction musculaire peuvent se produire."
}
},
{
"@type": "Question",
"name": "Comment le ryanodine affecte-t-il le cœur ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut provoquer des arythmies en modifiant le flux calcique dans les cardiomyocytes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques liés au ryanodine ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des tremblements ou des spasmes peuvent être observés."
}
},
{
"@type": "Question",
"name": "Le ryanodine influence-t-il la respiration ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysfonction musculaire peut affecter les muscles respiratoires."
}
},
{
"@type": "Question",
"name": "Comment prévenir les effets indésirables du ryanodine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance médicale régulière et un ajustement de la dose sont essentiels."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations alimentaires pour les utilisateurs de ryanodine ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée en calcium et en électrolytes est recommandée."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils éviter certains médicaments avec le ryanodine ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les médicaments qui affectent le calcium sans avis médical."
}
},
{
"@type": "Question",
"name": "Comment évaluer le risque d'effets secondaires ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests réguliers de la fonction musculaire et cardiaque sont conseillés."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il important lors de l'utilisation du ryanodine ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier permet de détecter rapidement les complications."
}
},
{
"@type": "Question",
"name": "Comment le ryanodine est-il utilisé en traitement ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est utilisé pour traiter certaines myopathies et troubles du calcium."
}
},
{
"@type": "Question",
"name": "Le ryanodine est-il administré par voie orale ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il est généralement administré par injection ou perfusion intraveineuse."
}
},
{
"@type": "Question",
"name": "Quels médicaments interagissent avec le ryanodine ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments affectant le calcium, comme les bloqueurs des canaux calciques, peuvent interagir."
}
},
{
"@type": "Question",
"name": "Le ryanodine est-il utilisé en anesthésie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être utilisé pour prévenir des complications musculaires pendant l'anesthésie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des alternatives au ryanodine ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, d'autres agents modulant le calcium peuvent être utilisés selon les besoins."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le ryanodine ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des arythmies et des troubles musculaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Le ryanodine peut-il causer des dommages permanents ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dommages permanents sont rares mais possibles en cas d'utilisation prolongée."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées au ryanodine ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une intervention médicale rapide et un ajustement du traitement sont nécessaires."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles avec une surveillance adéquate."
}
},
{
"@type": "Question",
"name": "Le ryanodine peut-il interagir avec d'autres traitements ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des interactions avec d'autres traitements peuvent augmenter le risque de complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque liés au ryanodine ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de troubles musculaires et cardiaques augmentent les risques."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les risques associés au ryanodine ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus sensibles aux effets du ryanodine."
}
},
{
"@type": "Question",
"name": "Y a-t-il des prédispositions génétiques au ryanodine ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines conditions génétiques peuvent augmenter la sensibilité au ryanodine."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie affectent-elles les risques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le tabagisme ou l'alcool peuvent augmenter les risques."
}
},
{
"@type": "Question",
"name": "Les interactions médicamenteuses sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines interactions peuvent exacerber les effets indésirables du ryanodine."
}
}
]
}
]
}
Blood donation services need to increase plasma donations to match the rising demand. However, evidence on how to best recruit donors among whole-blood donors is limited. Therefore, this study evaluat...
An online experiment with 246 German Red Cross whole-blood donors (possibility of plasma donation, blood group AB) was conducted using a 2 × 2 factorial, between-subject setup, and a pre-post treatmen...
The intention to donate plasma was low, but increased with treatment (mean value...
A conversion strategy based on making donors aware of their response efficacy is a promising way to optimize donor panels by shifting them to where they have the greatest impact. However, this study a...
Oxylipins, the oxidative metabolites of polyunsaturated fatty acids (PUFAs), serve as key mediators of oxidative stress, inflammatory responses, and vasoactive reactions in vivo. Our previous work has...
We conducted a prospective observational study of 12 patients undergoing elective cardiac surgery with expected CPB procedure. We collected venous and arterial blood samples before CPB, 15 and 45 min ...
Our results revealed that most venous plasma diols and hydroxy- oxylipins decreased after CPB initiation, with a continuous decline until the termination of CPB. Nevertheless, no statistically signifi...
CPB decreases numerous diols and hydroxy oxylipins in blood plasma, whereas no changes in erythrocytes oxylipins are observed during this procedure in patients undergoing cardiac surgery. As lipid med...
Plasma is often transfused to patients with bleeding or requiring invasive procedures and with abnormal tests of coagulation. Chart audits find half of plasma transfusions unnecessary, resulting in av...
Data were extracted on adult inpatients in 2017 at five academic sites from the hospital electronic chart, laboratory information systems and the Canadian Institute for Health Information Discharge Ab...
In 1 year, 2590 patients received 6088 plasma transfusions encompassing 11,490 units of plasma occurred at the five sites. 77.7% of events were either outside indications or under-dosed. Of these, 34....
The majority of plasma transfusions are sub-optimal. Local hospital culture may be an important driver. Electronic audits, with definitions employed in this study, may be a practical alternative to co...
With an intricate symptom pattern involving a dysregulated host response to infection, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause severe inflammation and cytokine storm...
Plasma is a commonly used blood product and is available in the form of fresh frozen plasma (FFP) or pooled solvent/detergent-treated plasma. In the Netherlands, solvent/detergent-treated plasma has b...
A preterm neonate developed lung bleeding at day 8 postpartum, for which intubation and mechanical ventilation was required and transfusions with packed red blood cells and plasma, in the form of FFP,...
A neonate experienced an acute haemolytic reaction, most probably caused by administrating a FFP product containing auto-antibodies. If transfused with solvent/detergent-treated plasma, such antibodie...
Objective Allergic reactions are a severe complication of plasma exchange (PEx). Few reports have analyzed allergic reactions during PEx using fresh-frozen plasma (FFP) as a replacement solution. We t...
The esterase status of blood plasma can claim to be one of the universal markers of various diseases; therefore, it deserves attention when searching for markers of the severity of COVID-19 and other ...
Discovery of diagnostic biomarkers for age-related neurodegenerative pathologies (NDDs) is essential for accurate diagnosis, following disease progression and drug development. Blood plasma and blood ...
Depression is a complex and multifactorial disease, affecting about 6.5% of the elderly population in what is referred to as late-life depression (LLD). Despite its public health relevance, there is s...